Home
Blog
Resources
About Us
Contact
Services
Institutions
Market Impact Report
Sign up
Log in
Home
Blog
Resources
About Us
Contact
Services
Institutions
Market Impact Report
Log in
Sign up
×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks
Home
DPLO
News
DPLO –
diplomat pharmacy inc
(US:NYSE)
DELAYED
$
usd
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DPLO
SPY
QQQ
SPX
News
Earning News
Analyst Actions
SEC Filings
Date
Time
Symbol
Headline
Impact
7/3
08:30 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) had its price target raised by analysts at Morgan Stanley from $16.00 to $21.00. They now have an "equal weight" rating on the stock.
Low
6/22
07:26 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) had its "outperform" rating re-affirmed by analysts at Leerink Swann. They now have a $33.00 price target on the stock.
Low
6/16
02:03 am
dplo
Diplomat Pharmacy Inc (NYSE: DPLO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.
Medium
6/5
05:18 pm
dplo
Diplomat Grants CEO Brian Griffin Inducement Awards Pursuant To NYSE Rule 303A.08
Low
5/15
04:40 pm
dplo
Diplomat Pharmacy Integrates With New Leadership [The Motley Fool]
Low
5/10
02:40 pm
dplo
Why Diplomat Pharmacy Stock Jumped Today [The Motley Fool]
Low
5/10
10:37 am
dplo
Diplomat Pharmacy names new chief, shares up 13% [Seeking Alpha]
Low
5/10
10:08 am
dplo
Diplomat Pharmacy (NYSE: DPLO) was upgraded by analysts at JPMorgan Chase from a "neutral" rating to an "overweight" rating.
Low
5/10
09:00 am
dplo
BRIEF-Diplomat Pharmacy Appoints Brian Griffin As CEO And Chairman Of Board [Reuters]
Medium
5/10
08:35 am
dplo
Diplomat Pharmacy Appoints Brian Griffin as Chief Executive Officer and Chairman of the Board
High
5/9
09:14 pm
dplo
Diplomat Pharmacy (NYSE: DPLO) was upgraded by analysts at Zacks Investment Research from a "strong sell" rating to a "hold" rating.
High
5/8
01:53 pm
dplo
Diplomat Pharmacy 2018 Q1 - Results - Earnings Call Slides [Seeking Alpha]
Low
5/8
11:36 am
dplo
Diplomat Pharmacy's (DPLO) Interim CEO Jeff Park on Q1 2018 Results - Earnings Call Transcript [Seeking Alpha]
Low
5/8
07:00 am
dplo
Diplomat Pharmacy in Final Stages of CEO Search Process
Medium
5/7
04:47 pm
dplo
Diplomat Pharmacy misses by $0.02, beats on revenue [Seeking Alpha]
Medium
5/7
04:38 pm
dplo
Diplomat Announces Strong 1st Quarter Financial Results
Medium
5/7
12:30 pm
dplo
Diplomat Pharmacy, Inc. to Host Earnings Call
Low
5/2
12:11 am
dplo
Diplomat Pharmacy (NYSE: DPLO) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.
Low
5/1
04:15 pm
dplo
Diplomat to Participate in 43rd Annual Deutsche Bank Health Care Conference
Low
4/30
08:00 am
dplo
Diplomat Launches CastiaRx, Industry-Leading Specialty Benefit Manager
Medium
4/23
04:15 pm
dplo
Diplomat to Release Q1 2018 Operating Results, Host Conference Call on May 7
Low
Live Event:
Click Here To Register For The Live Online Workshop
Latest Posts
From the Macro-economy to Personal Money Management: Registration Opportunity for Wealth Conference
NewsQuantified Founder to Appear at Major Investing Conference: Free Registration Opportunity for Wealth365
Stock Market Sectors: A Strategic Overview
Metrics Deep Dive Continued: Pricing Profits, Reining in Risk
Metrics Deep Dive: Balance Sheet Basics, Cash Flow Clarity